Proto Labs

PRLBNYSEUSD

THESIS ALERT

Email me when the PRLB thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$69.11
+$1.18 (+1.74%)Today 1M −27.61%
After hours$69.110.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$67.93
Prior regular-session close from the quote source.
$68.65–$70.33
Regular-session low and high so far today.
241.7K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$46.07–$99.96
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own PRLB if speed and quoting advantages translate into renewed profitable growth, not just stable niche economics.

PRLB price history

Latest price$69.11Today+$1.18 (+1.74%)
PRLB -25.66%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Engineers and procurement teams continue to value Proto Labs’ rapid custom-parts workflow enough that demand converts into profitable orders rather than leaking to lower-priced marketplaces or local shops.HoldingMateriality: High

    GAAP annual revenue increased from $500.9 million in FY2024 to $533.1 million in FY2025, indicating renewed order conversion after a flat FY2023-FY2024 period. If the speed advantage holds, revenue can grow without a price war; if it fades, Proto Labs becomes a slower-growth job shop with weaker pricing power.

    Watch: Xometry or Fictiv materially narrows lead-time and manufacturability-feedback gaps while undercutting Proto Labs on price.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue increased from $500.9 million in FY2024 to $533.1 million in FY2025, indicating renewed order conversion after a.

    Open source ↗
  • Proto Labs’ combination of process expertise, manufacturing breadth, and rapid fulfillment preserves pricing power, so growth does not require gross-margin sacrifice.StrengtheningMateriality: High

    GAAP annual gross profit rose from $223.2 million in FY2024 to $237.1 million in FY2025. Gross margin is the clearest test of whether Proto Labs is selling differentiated speed or merely buying volume with lower prices.

    Watch: Marketplace competitors make custom-part pricing transparent enough that customers route standard jobs to the lowest bidder.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit rose from $223.2 million in FY2024 to $237.1 million in FY2025.

    Open source ↗
  • The self-service quoting and automated manufacturing model should allow incremental demand to produce operating leverage, but the evidence is not yet strong enough to prove a durable margin inflection.HoldingMateriality: Medium

    GAAP annual operating income improved from $19.9 million in FY2024 to $25.1 million in FY2025. The equity upside depends on Proto Labs becoming more than a steady gross-margin business; operating leverage is what turns revenue recovery into per-share value.

    Watch: More orders require manual engineering support, sales involvement, or quality intervention, weakening the automation thesis.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income improved from $19.9 million in FY2024 to $25.1 million in FY2025.

    Open source ↗
  • The short-cycle custom manufacturing model and working-capital discipline continue to convert accounting profit into cash that can fund investment without stressing the balance sheet.StrengtheningMateriality: Medium

    GAAP annual operating cash flow was $74.5 million in FY2025 versus GAAP annual net income of $21.2 million. Strong cash conversion gives management room to reinvest, repurchase shares, or withstand manufacturing downturns; weak conversion would make modest earnings less valuable.

    Watch: A shift toward larger production jobs lengthens receivables cycles or requires more inventory, reducing working-capital efficiency.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was $74.5 million in FY2025 versus GAAP annual net income of $21.2 million.

    Open source ↗
  • A cash-rich, low-liability balance sheet gives Proto Labs the option to invest through cyclical weakness and avoid forced financing while the growth thesis is being tested.StrengtheningMateriality: Medium

    Cash was $110.8 million at FY2025 year-end, up from $89.1 million at FY2024 year-end and $56.6 million at FY2022 year-end. Balance-sheet strength lowers existential risk and increases management’s strategic flexibility, but it does not by itself solve the growth problem.

    Watch: Management uses cash for a large acquisition that fails to improve customer reach, manufacturing breadth, or margins.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash was $110.8 million at FY2025 year-end, up from $89.1 million at FY2024 year-end and $56.6 million at FY2022 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Engineers and procurement teams continue to value Proto Labs’ rapid custom-parts workflow enough that demand converts into profitable orders rather than leaking to lower-priced marketplaces or local shops. If the speed advantage holds, revenue can grow without a price war; if it fades, Proto Labs becomes a slower-growth job shop with weaker pricing power.

Proto Labs’ combination of process expertise, manufacturing breadth, and rapid fulfillment preserves pricing power, so growth does not require gross-margin sacrifice. Gross margin is the clearest test of whether Proto Labs is selling differentiated speed or merely buying volume with lower prices.

The self-service quoting and automated manufacturing model should allow incremental demand to produce operating leverage, but the evidence is not yet strong enough to prove a durable margin inflection. The equity upside depends on Proto Labs becoming more than a steady gross-margin business; operating leverage is what turns revenue recovery into per-share value.

The short-cycle custom manufacturing model and working-capital discipline continue to convert accounting profit into cash that can fund investment without stressing the balance sheet. Strong cash conversion gives management room to reinvest, repurchase shares, or withstand manufacturing downturns; weak conversion would make modest earnings less valuable.

A cash-rich, low-liability balance sheet gives Proto Labs the option to invest through cyclical weakness and avoid forced financing while the growth thesis is being tested. Balance-sheet strength lowers existential risk and increases management’s strategic flexibility, but it does not by itself solve the growth problem.

All standing thesis claims
Original report summary

speed and quoting advantages translate into renewed profitable growth, not just stable niche economics.

Evidence assessed Oct 13, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Proto Labs

Where the evidence on Proto Labs stands: Holding on the latest evidence (Oct 13, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Engineers and procurement teams continue to value Proto Labs’ rapid custom-parts workflow enough that demand converts into profitable orders rather than leaking to lower-priced marketplaces or local shops.

    sec.gov ↗

  • Proto Labs’ combination of process expertise, manufacturing breadth, and rapid fulfillment preserves pricing power, so growth does not require gross-margin sacrifice.

    sec.gov ↗

  • The self-service quoting and automated manufacturing model should allow incremental demand to produce operating leverage, but the evidence is not yet strong enough to prove a durable margin inflection.

    sec.gov ↗

  • The short-cycle custom manufacturing model and working-capital discipline continue to convert accounting profit into cash that can fund investment without stressing the balance sheet.

    sec.gov ↗

  • A cash-rich, low-liability balance sheet gives Proto Labs the option to invest through cyclical weakness and avoid forced financing while the growth thesis is being tested.

    sec.gov ↗

Bear case: what would count against it

  • Xometry or Fictiv materially narrows lead-time and manufacturability-feedback gaps while undercutting Proto Labs on price.

    sec.gov ↗

  • Marketplace competitors make custom-part pricing transparent enough that customers route standard jobs to the lowest bidder.

    sec.gov ↗

  • More orders require manual engineering support, sales involvement, or quality intervention, weakening the automation thesis.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Proto Labs

No break has crossed Proto Labs’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Regulation FD disclosure.

    Proto Labs filed an SEC 8-K on 2026-08-24: Regulation FD disclosure. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Proto Labs filed an SEC 8-K on 2026-07-31: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Director or principal officer change.

    Proto Labs filed an SEC 8-K on 2026-05-20: Director or principal officer change. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Xometry or Fictiv materially narrows lead-time and manufacturability-feedback gaps while undercutting Proto Labs on price.
  • Marketplace competitors make custom-part pricing transparent enough that customers route standard jobs to the lowest bidder.
  • More orders require manual engineering support, sales involvement, or quality intervention, weakening the automation thesis.
  • A shift toward larger production jobs lengthens receivables cycles or requires more inventory, reducing working-capital efficiency.
  • Management uses cash for a large acquisition that fails to improve customer reach, manufacturing breadth, or margins.

PRLB news

Loading headlines…

Financial statements

PRLB income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

PRLB: quick answers

Have members of Congress traded PRLB?
5 trades in PRLB have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed PRLB trade
Which well-known investors own PRLB?
1 of the 37 well-known funds tracked here reported PRLB shares in their latest 13F filing. By share of the fund's portfolio: ARK Investment Management (Cathie Wood), 0.0%. Fund portfolios

PRLB in well-known investors’ portfolios

1 of 37 funds reported PRLB shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Cathie WoodARK Investment Management0.02%$2.9M−22.5%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.